NCT07737821

Brief Summary

The goal of this clinical trial is to learn if improv comedy helps reduce anxiety symptoms and improve mental well-being in Chinese young adults in Hong Kong. The main questions it aims to answer are:

  1. 1.Does improv comedy reduce anxiety symptoms?
  2. 2.Does improv comedy improve mental well-being?
  3. 3.Attend weekly three-hour improv comedy workshops for 4 consecutive weeks
  4. 4.Complete four assessments and brief reflections during or around the workshop sessions
  5. 5.Take part in up to two individual interviews (optional)

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable anxiety

Timeline
25mo left

Started Aug 2026

Typical duration for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 22, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 30, 2026

Completed
16 days until next milestone

Study Start

First participant enrolled

August 15, 2026

Expected
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2028

1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2028

Last Updated

July 30, 2026

Status Verified

July 1, 2026

Enrollment Period

2 years

First QC Date

July 22, 2026

Last Update Submit

July 28, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Mean change from baseline in anxiety symptoms measured by the GAD-7 at Week 2, Week 4, and Week 6

    The Generalized Anxiety Disorder 7-Item Scale (GAD-7) ranges from 0 to 21, with higher scores indicating greater anxiety symptoms.

    Baseline (pre-intervention), Week 2 (mid-treatment), Week 4 (post-intervention), and Week 6 (2-week follow-up)

  • Mean change from baseline in mental well-being measured by the WHO-5 at Week 2, Week 4, and Week 6

    The World Health Organization-Five Well-Being Index (WHO-5) ranges from 0 to 25, with higher scores indicating better mental well-being.

    Baseline (pre-intervention), Week 2 (mid-treatment), Week 4 (post-intervention), and Week 6 (2-week follow-up)

Secondary Outcomes (15)

  • Mean change from baseline in depression symptoms measured by the PHQ-9 at Week 2, Week 4, and Week 6

    Baseline (pre intervention), Week 2 (mid treatment), Week 4 (post intervention), and Week 6 (2 week follow up)

  • Mean change from baseline in worry measured by the PSWQ-A at Week 2, Week 4, and Week 6

    Baseline (pre intervention), Week 2 (mid treatment), Week 4 (post intervention), and Week 6 (2 week follow up)

  • Mean change from baseline in sleep disturbance measured by the ISI at Week 2, Week 4, and Week 6

    Baseline (pre intervention), Week 2 (mid treatment), Week 4 (post intervention), and Week 6 (2 week follow up)

  • Mean change from baseline in perceived stress measured by the PSS-4 at Week 2, Week 4, and Week 6

    Baseline (pre intervention), Week 2 (mid treatment), Week 4 (post intervention), and Week 6 (2 week follow up)

  • Mean changes from baseline in positive and negative affect measured by the I-PANAS-SF at Week 2, Week 4, and Week 6

    Baseline (pre intervention), Week 2 (mid treatment), Week 4 (post intervention), and Week 6 (2 week follow up)

  • +10 more secondary outcomes

Study Arms (2)

Improv Against Anxiety (IAA)

EXPERIMENTAL

Improv Against Anxiety (IAA) is a structured, group-based improv comedy program consisting of four weekly 3-hour sessions. Sessions use established improv comedy games and exercises to reduce anxiety symptoms and enhance mental well-being.

Behavioral: Improv Against Anxiety (IAA)

Waitlist Control

NO INTERVENTION

Participants assigned to the waitlist control arm do not receive the IAA intervention during the main study period but complete the same assessment schedule as the experimental arm. During the wait period, they may seek or continue usual care from mental health professionals (treatment as usual). After all primary outcome assessments are completed, they are offered the opportunity to participate in the IAA intervention.

Interventions

Improv Against Anxiety (IAA) is a structured, group-based improv comedy program consisting of four weekly 3-hour sessions. Sessions use established improv games and exercises to reduce anxiety symptoms and enhance mental well-bein

Improv Against Anxiety (IAA)

Eligibility Criteria

Age18 Years - 29 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Ethnic Chinese, fluent in spoken Mandarin and able to read Chinese
  • Never married and without children
  • No current or past diagnosis of any mental disorder (e.g. anxiety disorders, depressive disorders, bipolar disorder, psychotic disorders)
  • Mild to moderate anxiety symptoms (defined as a GAD-7 total score between 5 and 14)
  • No prior experience of formal performance training in drama
  • Availability to attend at least 3 out of 4 weekly sessions over the 4-week intervention period upon enrolment

You may not qualify if:

  • Unstable or severe chronic physical illness that would contraindicate participation in group activities or light-to-moderate physical movement (e.g., uncontrolled hypertension, severe asthma, acute cardiovascular events within the past 6 months)
  • Moderately severe to severe depression symptoms (defined as a PHQ-9 total score greater than 14)
  • Suicidal ideation (defined as a score greater than 0 on item 9 of the PHQ-9)
  • Potential risky drinking behavior (defined as AUDIT-C total score greater than 4)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre on Behavioral Health, The University of Hong Kong

Hong Kong, Hong Kong

Location

MeSH Terms

Conditions

Anxiety DisordersPsychological Well-Being

Condition Hierarchy (Ancestors)

Mental DisordersPersonal SatisfactionBehavior

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 22, 2026

First Posted

July 30, 2026

Study Start (Estimated)

August 15, 2026

Primary Completion (Estimated)

July 31, 2028

Study Completion (Estimated)

August 31, 2028

Last Updated

July 30, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

We do not have current plans to share individual participant data.

Locations